A AXOGEN INC
| Market Cap | $1.79B |
| P/E Ratio | — |
| Forward P/E | 44.56 |
| Dividend Yield | — |
| Beta | 0.98 |
| 52W Range | $9.29 - $35.38 |
| # Hedge Funds | 2 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 2 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| First Eagle Investment Management First Eagle Investment Management | 0.02% | $13.34M | 407,593 | Reduce 5.62% |
| Mairs & Power Growth Fund Mairs & Power Inc | 0.01% | $720.00K | 22,000 | — |
Insider Trading
| Insider Name of the company insider who made the trade 36 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| DeVinney Erick WayneChief Innovation Officer | Sale | 5,221 | $32.84 | $171.46K | 16 Mar 2026 | 16 Mar 2026 |
| Weiler Kathy Johnson | Sale | 21,825 | $29.55 | $644.86K | 16 Dec 2025 | 17 Dec 2025 |
| Wendell Amy McBride | Sale | 5,000 | $29.31 | $146.56K | 16 Dec 2025 | 17 Dec 2025 |
| Weiler Kathy Johnson | Sale | 6,580 | $29.55 | $194.44K | 16 Dec 2025 | 17 Dec 2025 |
| Weiler Kathy Johnson | Sale | 18,248 | $29.55 | $539.17K | 16 Dec 2025 | 17 Dec 2025 |
| Wendell Amy McBride | Sale | 18,248 | $29.31 | $534.89K | 16 Dec 2025 | 17 Dec 2025 |
| Wendell Amy McBride | Sale | 20,436 | $29.31 | $599.02K | 16 Dec 2025 | 17 Dec 2025 |
| Hartley Lindsey MarieCFO | Sale | 14,812 | $29.86 | $442.29K | 15 Dec 2025 | 17 Dec 2025 |
| Began Marc AEVP & General Counsel | Sale | 13,222 | $30.00 | $396.66K | 11 Dec 2025 | 12 Dec 2025 |
| DALE MICHAEL DChief Executive Officer | Sale | 25,000 | $30.00 | $750.00K | 10 Dec 2025 | 12 Dec 2025 |
| DALE MICHAEL DChief Executive Officer | Sale | 61,463 | $31.21 | $1.92M | 09 Dec 2025 | 10 Dec 2025 |
| DeVinney Erick WayneChief Innovation Officer | Sale | 19,517 | $31.21 | $609.09K | 09 Dec 2025 | 10 Dec 2025 |
| THOMAS PAUL | Sale | 21,399 | $29.61 | $633.71K | 09 Dec 2025 | 10 Dec 2025 |
| Kemp JensChief Marketing Officer | Sale | 8,156 | $31.21 | $254.53K | 09 Dec 2025 | 10 Dec 2025 |
| TYNDALL JOSEPH A. | Sale | 10,860 | $30.98 | $336.41K | 09 Dec 2025 | 10 Dec 2025 |
| TYNDALL JOSEPH A. | Sale | 14,248 | $30.98 | $441.36K | 09 Dec 2025 | 10 Dec 2025 |
| JOHNSON JOHN | Sale | 13,141 | $29.98 | $393.99K | 09 Dec 2025 | 10 Dec 2025 |
| JOHNSON JOHN | Sale | 8,545 | $29.98 | $256.20K | 09 Dec 2025 | 10 Dec 2025 |
| Began Marc AEVP & General Counsel | Sale | 9,278 | $31.21 | $289.55K | 09 Dec 2025 | 10 Dec 2025 |
| JOHNSON JOHN | Sale | 11,891 | $31.22 | $371.27K | 08 Dec 2025 | 10 Dec 2025 |
| JOHNSON JOHN | Sale | 11,802 | $31.26 | $368.93K | 08 Dec 2025 | 10 Dec 2025 |
| Hartley Lindsey MarieCFO | Sale | 2,854 | $31.56 | $90.07K | 08 Dec 2025 | 10 Dec 2025 |
| Hartley Lindsey MarieCFO | Sale | 11,533 | $31.56 | $363.94K | 08 Dec 2025 | 10 Dec 2025 |
| Burke William P. Mr. | Sale | 3,591 | $24.02 | $86.25K | 11 Nov 2025 | 13 Nov 2025 |
| Burke William P. Mr. | Sale | 19,227 | $24.01 | $461.64K | 10 Nov 2025 | 13 Nov 2025 |
| Burke William P. Mr. | Sale | 5,347 | $24.01 | $128.37K | 06 Nov 2025 | 07 Nov 2025 |
| Burke William P. Mr. | Sale | 11,431 | $24.05 | $274.89K | 05 Nov 2025 | 07 Nov 2025 |
| Burke William P. Mr. | Sale | 18,248 | $23.00 | $419.70K | 30 Oct 2025 | 31 Oct 2025 |
| Mr. P. Burke WilliamDirector | Sale | 18,248 | $23.00 | $419.70K | 30 Oct 2025 | 31 Oct 2025 |
| Burke William P. Mr. | Sale | 19,799 | $22.00 | $435.58K | 29 Oct 2025 | 31 Oct 2025 |
| Burke William P. Mr. | Sale | 20,436 | $19.15 | $391.44K | 29 Oct 2025 | 31 Oct 2025 |
| Mr. P. Burke WilliamDirector | Sale | 20,436 | $19.15 | $391.44K | 29 Oct 2025 | 31 Oct 2025 |
| Mr. P. Burke WilliamDirector | Sale | 19,799 | $22.00 | $435.58K | 29 Oct 2025 | 31 Oct 2025 |
| Burke William P. Mr. | Sale | 1,457 | $18.02 | $26.25K | 22 Oct 2025 | 24 Oct 2025 |
| Mr. P. Burke WilliamDirector | Sale | 1,457 | $18.02 | $26.25K | 22 Oct 2025 | 24 Oct 2025 |
| Burke William P. Mr. | Sale | 736 | $18.00 | $13.25K | 06 Oct 2025 | 07 Oct 2025 |
Frequently Asked Questions
What is AXGN stock price today?
AXOGEN INC (AXGN) is currently trading at $34.44. The stock has a 52-week range of $9.29 to $35.38 and a market capitalization of $1.79B.
Is AXGN a good stock to buy in 2026?
AXOGEN INC has a P/E ratio of N/A (forward P/E: 44.6), a dividend yield of none, and 1-year performance of +102.1%. 2 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling AXGN stock?
There have been 36 insider transactions for AXGN in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has AXGN stock performed over the past year?
AXOGEN INC (AXGN) has returned +102.1% over the past 12 months. The stock traded between $9.29 and $35.38 during this period, and is currently at $34.44.
Which hedge funds own AXGN (AXOGEN INC)?
2 tracked hedge funds currently hold AXGN in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is AXGN's market cap and valuation?
AXOGEN INC (AXGN) has a market capitalization of $1.79B. The trailing P/E ratio is N/A and forward P/E is 44.6. The stock is classified in the Healthcare sector.
What is AXGN's revenue and profitability?
AXOGEN INC reported revenue of $225.21M with net income of N/A and a profit margin of N/A. The stock has a beta of 0.98.
What sector is AXGN in and who are its biggest institutional holders?
AXOGEN INC (AXGN) operates in the Healthcare sector. It is held by 2 tracked hedge funds. See the ownership table above for the complete list.